{"id":"W2892218953","doi":"10.1200/jco.2017.35.15_suppl.4530","title":"Health-related quality of life (HRQoL) of pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated advanced urothelial cancer (UC) in KEYNOTE-045.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Discontinuation; Docetaxel; Quality of life (healthcare); Internal medicine; Urothelial cancer; Cancer; Proportional hazards model; Oncology; Bladder cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002523076,0.0004487509,0.001030376,0.0002096781,0.0002333064,0.0005755739,0.0005623657,0.0008839816,0.005460686],"category_scores_gemma":[0.001745012,0.0003259653,0.001337758,0.0003235182,0.000420576,0.0009018419,0.0006177503,0.001794454,0.0005252205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009982459,"about_ca_system_score_gemma":0.001019146,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001217204,"about_ca_topic_score_gemma":0.002405638,"domain_scores_codex":[0.9992187,0.0003293221,0.00005657512,0.000161089,0.00007169384,0.00016255],"domain_scores_gemma":[0.9992164,0.0001609412,0.0002255349,0.0000540875,0.00002958591,0.0003134962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8950765,0.01723816,0.02429516,0.0004933984,0.001764877,0.00007726047,0.0001692882,0.001589251,0.008970885,0.0001661461,0.002478075,0.04768091],"study_design_scores_gemma":[0.1732302,0.6653764,0.1485974,0.0001395718,0.002635724,0.0002136955,0.0001677683,0.002412222,0.003363502,0.0002476021,0.0035621,0.00005384395],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972783,0.0009530457,0.00009453185,0.0001360865,0.00004444177,0.0001653973,0.0006416668,0.00001131372,0.0006751671],"genre_scores_gemma":[0.9975944,0.0002637727,0.0001669063,0.0002325341,0.00003001188,0.0002052427,0.000905398,0.000002669062,0.000599071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005460686,"threshold_uncertainty_score":0.01826781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.177780165529481,"score_gpt":0.5218018808113934,"score_spread":0.3440217152819124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}